Bridgeway Capital Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-32,800
| Closed | -$99.7K | – | 1397 |
|
|
2023
Q4 | $99.7K | Buy |
+32,800
| New | +$99.7K | ﹤0.01% | 1241 |
|
|
2023
Q2 | – | Sell |
-69,584
| Closed | -$127K | – | 1466 |
|
|
2023
Q1 | $127K | Sell |
69,584
-50,000
| -42% | -$91K | ﹤0.01% | 1192 |
|
|
2022
Q4 | $197K | Hold |
119,584
| – | – | 0.01% | 1095 |
|
|
2022
Q3 | $230K | Buy |
119,584
+50,000
| +72% | +$96.2K | 0.01% | 1106 |
|
|
2022
Q2 | $208K | Buy |
+69,584
| New | +$208K | ﹤0.01% | 1084 |
|